Skip to main content
Investors
Media
open in a new window
Contact Us
open in a new window
|
Search
open in a new window
Company
Science & Medicine
Patients
Responsibility
Careers
IR Home
Why Invest
Events & Presentations
Corporate Governance
Governance Documents
Executive Management
Board of Directors
Committee Composition
Contact the Board
Financials
Quarterly Results
Annual Reports
SEC Filings
Investor FAQs
Press Releases
Investor Contacts
Investor Emails Alerts
RSS Feeds
IR Home
Why Invest
Events & Presentations
Corporate Governance
Governance Documents
Executive Management
Board of Directors
Committee Composition
Contact the Board
Financials
Quarterly Results
Annual Reports
SEC Filings
Investor FAQs
Press Releases
Investor Contacts
Investor Emails Alerts
RSS Feeds
Close
Close
Investors
Company
Product
Research & Development
Patients
Partnerships
Careers
Close
Press Releases
Normal
Press Release RSS Feed (opens in new window)
Press release year list
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
February 27, 2023
Ironwood Pharmaceuticals to Participate in Upcoming Investor Conferences
February 16, 2023
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Results
February 13, 2023
Ironwood Pharmaceuticals Announces FDA Filing Acceptance and Priority Review of Supplemental New Drug Application for LINZESS® (linaclotide) for Functional Constipation in Children and Adolescents Ages 6-17 Years-Old
February 2, 2023
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2022 Investor Update Call
January 9, 2023
Ironwood Pharmaceuticals Provides Update on FY 2022 Financial Guidance and Announces FY 2023 Financial Guidance
January 4, 2023
Ironwood Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference